Alan Lewis, Director at BIOMARIN PHARMACEUTICAL INC (BMRN), sold 20,000 shares at $20.24 ($402K) on 2007-08-10, disclosed to the SEC on 2007-08-14.
Open-market sale of $402k BMRN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.00 | 8,300 | $166K | 41.3% |
| 2 | $20.01 | 200 | $4K | 1.0% |
| 3 | $20.03 | 200 | $4K | 1.0% |
| 4 | $20.07 | 1,600 | $32K | 8.0% |
| 5 | $20.08 | 200 | $4K | 1.0% |
| 6 | $20.09 | 1,000 |
| $20K |
| 5.0% |
| 7 | $20.11 | 200 | $4K | 1.0% |
| 8 | $20.12 | 200 | $4K | 1.0% |
| 9 | $20.13 | 1,600 | $32K | 8.0% |
| 10 | $20.14 | 800 | $16K | 4.0% |
| 11 | $20.15 | 600 | $12K | 3.0% |
| 12 | $20.16 | 1,000 | $20K | 5.0% |
| 13 | $20.17 | 600 | $12K | 3.0% |
| 14 | $20.18 | 1,500 | $30K | 7.5% |
| 15 | $20.19 | 1,100 | $22K | 5.5% |
| 16 | $20.21 | 300 | $6K | 1.5% |
| 17 | $20.23 | 100 | $2K | 0.5% |
| 18 | $20.24 | 100 | $2K | 0.5% |
| 19 | $20.25 | 400 | $8K | 2.0% |
| Total | $20.08 avg | 20,000 | $402K | 100% |
| Filing → |
| BMRN | SELL | 2014-12-08 | $674K | — | Filing → |
| BMRN | SELL | 2013-12-11 | $1.6M | — | Filing → |
| BMRN | SELL | 2013-02-28 | $1.3M | — | Filing → |